What Biopharma Consultancy does

BioPharma Consultants is a privately held management consulting firm founded in 2001 by Leisa Dennehy and headquartered in Chapel Hill, North Carolina, operating under the legal entity BioPharma Strategies Group, Inc. The firm delivers marketing strategy, corporate development, commercial advisory, and interim staffing services to biotech and pharmaceutical companies worldwide, with a service portfolio organized into seven modules: technology/portfolio commercial assessment, commercial development planning, pre-launch brand planning, post-launch brand management, corporate development, business development, and life cycle/generic defense planning. Work is project-based, delivered by a small core team (1-10 employees) led by the founder and extended through a network of strategic partners spanning investment banking, venture capital, legal, accounting, regulatory, and clinical disciplines.

The firm serves a horizontal mix of small biotech startups, mid-stage biotechs, and large multinational pharmaceutical companies, with named engagements involving GlaxoSmithKline, Glaxo Wellcome, Procter & Gamble, Shire Pharmaceuticals, Grifols, United Therapeutics, and MicuRx (China), alongside due diligence support for J.P. Morgan Partners and Perseus Soros. The firm operates with no proprietary technology platform, API, or AI capabilities; revenue is generated entirely through professional services fees from direct client engagements. Geographic reach is global, with first-hand delivery experience in the US, China, and Europe, and the practice markets established international perspective in life sciences commercial strategy as its primary differentiator over competing generalist consultancies.

Name

Biopharma Consultancy

Legal name

BioPharma Strategies Group, Inc.

Website

https://biopharma-consultants.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

1–10 employees

Short description

BioPharma Consultants is a private biopharma management consulting firm founded in 2001, led by Leisa Dennehy, that provides marketing strategy, corporate development, commercial advisory, and interim staffing to pharmaceutical and biotechnology companies worldwide.

Ownership category

akta.pro rank

Product category

Pharmaceutical Consulting

NAICS

Marketing Consulting Services (541613), Management Consulting Services (54161), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Strategy & Corporate Development Consulting (BPAHACAA)

akta.pro secondary industries

Brand & Portfolio Strategy Consulting (MPAAAFAB), Corporate Strategy Advisory (BPAHADAA), Life Sciences & Biotech (R&D/Clinical) Staffing (BPACADAL)

Keywords

• Pharmaceutical consulting services
• Biotech commercial strategy
• Pharma marketing strategy
• Corporate development advisory
• Interim pharmaceutical staffing

Headquarters

HQ city

Chapel Hill

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Management Consulting Services: Professional consulting services delivered through project-based engagements. Services include marketing strategy, corporate development, interim staffing, and commercial advisory for biotech and pharmaceutical companies worldwide.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

BioPharma Consultants provides management consulting, marketing strategy, corporate development, and interim staffing services for biotech and pharmaceutical companies worldwide. The firm delivers specialized advisory across the product lifecycle — from technology/portfolio commercial assessment, commercial development planning, and pre-launch brand planning through post-launch brand management, corporate development, business development, and life-cycle/generic defense planning — through direct, founder-led consulting engagements.

Product overview

BioPharma Consultancy is a management consulting firm offering a portfolio of advisory services for biotech and pharmaceutical companies. The company provides six interconnected consulting service modules: Technology/Portfolio Commercial Assessment (analyzes science-based IP and product potential), Commercial Development Planning (strategic positioning for market entry), Pre-Launch Brand Planning (full launch execution support), Post-Launch Brand Management (profitability optimization), Corporate Development (financing and organizational strategies), Business Development (licensing partner identification), and Life Cycle/Generic Defense Planning (patent expiration strategy). These services are delivered by experienced pharmaceutical industry professionals and can be engaged individually or as an integrated engagement to support companies at all stages from early development through commercial operations.

Differentiator

Problem solved

Functional benefit

Products and services

• Technology / Portfolio Commercial Assessment Deep dive analysis into the science, medical potential, and customer uptake of products producing revenue forecasts and product potential insights. Includes market-optimized development plans, marketing strategy refinement, and licensing negotiation support, for biotech and pharmaceutical companies.
• Commercial Development Planning Strategic analysis and development planning for competitive positioning and market entry requirements for new or existing products, including clinical program design and manufacturing recommendations, delivered to biotech and pharmaceutical companies.
• Pre-Launch Brand Planning Full product launch planning and execution support from ground zero across all functions, including brand marketing and sales launch plans. Provides interim experienced talent during busy launch periods for biotech and pharmaceutical companies.
• Post-Launch Brand Management Short-term interim support and strategic analysis to maximize marketing opportunities post-launch, including profitability improvements and sales force effectiveness recommendations, for biotech and pharmaceutical companies.
• Corporate Development Creation, planning, and implementation of corporate financing and organizational strategies to cultivate shareholder value, including product and market analyses and investment capital positioning, for biotech and pharmaceutical companies.
• Business Development Development of targeted business development ideas for new products and identification of potential licensing partners, including partner engagement and deal closing assistance, for biotech and pharmaceutical companies.
• Life Cycle / Generic Defense Planning Strategic analysis and recommendations to maximize brand opportunities prior to patent expiration, including sales force optimization, P&L enhancement, reformulation options, and generic brand opportunity analysis, for biotech and pharmaceutical companies.

Quantifiable outcome

• Product contribution profit margin increased by one-third while revenue declined by only 1% through strategic sales force reallocation
• +2 more outcomes

Named customers8 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves5 records

Expansion highlights3 records

Direct peers

• Health Advances: Specialized strategy consulting firm serving pharma, biotech, and medtech with commercial strategy, due diligence, and corporate development services. Highly comparable service mix and customer base to BioPharma.
• DeciBio: Life-sciences strategy consulting firm offering market intelligence, commercial strategy, and analytics for biotech and pharma. Comparable as a boutique competitor targeting the same commercial-strategy buyer.
• ClearView Healthcare Partners: Boutique strategy consulting firm focused on pharmaceutical and biotech clients across commercial, portfolio, and corporate development mandates. Closely comparable in size, founder-led model, and exclusive pharma/biotech focus.

Broad incumbents

• ZS Associates: Large global consulting firm with deep pharma and biotech commercial, sales, and marketing practice. Overlaps with BioPharma on commercial strategy and launch planning but at vastly greater scale and breadth.
• IQVIA (Consulting & Services): Global life-sciences analytics and consulting powerhouse covering commercial strategy, launch, and market access. A scaled incumbent that competes for the same pharma commercialization mandates.
• Simon-Kucher & Partners: Global consulting firm with significant life-sciences pricing, access, and commercial strategy practice. Overlaps with BioPharma on commercial advisory and launch strategy.

Peers

• McKinsey & Company (Pharma & Medical Products):

Market position

Weaknesses4 records

Competitive moat4 records

Key risks2 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biopharma Consultancy